Vera Novak

Vera Novak

Harvard University

H-index: 60

North America-United States

About Vera Novak

Vera Novak, With an exceptional h-index of 60 and a recent h-index of 35 (since 2020), a distinguished researcher at Harvard University, specializes in the field of neuroscience, diabetes.

His recent articles reflect a diverse array of research interests and contributions to the field:

Dropout risk and effectiveness of retention strategies in the Memory Advancement by Intranasal Insulin in Type 2 Diabetes (MemAID) Clinical Trial

Daily intranasal insulin at 40IU does not affect food intake and body composition: A placebo-controlled trial in older adults over a 24-week period with 24-weeks of follow-up

Safety of intranasal insulin in type 2 diabetes on systemic insulin: a double-blinded placebo-controlled sub-study of memaid trial

Depressive symptoms exacerbate disability in older adults: A prospective cohort analysis of participants in the MemAID trial

MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial

1503-PUB: Modeling the Prediction of Improvement on Gait and Cognition among Patients Receiving Intranasal Insulin

219-OR: intranasal insulin enhanced resting-state functional connectivity of medio-prefrontal cortex in type 2 diabetes: a substudy of the memory advancement with type 2 …

879-P: Dropout Risk and Effectiveness of Retention Strategies: A Substudy of the Memory Advancement by Intranasal Insulin (INI) in Type 2 Diabetes (MemAID)

Vera Novak Information

University

Position

Associate Professor of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School

Citations(all)

10841

Citations(since 2020)

3793

Cited By

8617

hIndex(all)

60

hIndex(since 2020)

35

i10Index(all)

123

i10Index(since 2020)

92

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Vera Novak Skills & Research Interests

neuroscience

diabetes

Top articles of Vera Novak

Title

Journal

Author(s)

Publication Date

Dropout risk and effectiveness of retention strategies in the Memory Advancement by Intranasal Insulin in Type 2 Diabetes (MemAID) Clinical Trial

Contemporary Clinical Trials

Daniel F Isaza-Pierrotti

Faizan Khan

Peter Novak

Vasileios Lioutas

Christos S Mantzoros

...

2023/2/1

Daily intranasal insulin at 40IU does not affect food intake and body composition: A placebo-controlled trial in older adults over a 24-week period with 24-weeks of follow-up

Clinical Nutrition

Laura Aponte Becerra

Anna Gavrieli

Faizan Khan

Peter Novak

Vasileios Lioutas

...

2023/6/1

Safety of intranasal insulin in type 2 diabetes on systemic insulin: a double-blinded placebo-controlled sub-study of memaid trial

Archives of diabetes & obesity

L Aponte Becerra

B Galindo Mendez

F Khan

V Lioutas

P Novak

...

2022

Depressive symptoms exacerbate disability in older adults: A prospective cohort analysis of participants in the MemAID trial

PLoS one

Stephanie S Buss

Laura Aponte Becerra

Jorge Trevino

Catherine B Fortier

Long H Ngo

...

2022/11/29

MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial

Journal of neurology

Vera Novak

Christos S Mantzoros

Peter Novak

Regina McGlinchey

Weiying Dai

...

2022/9

1503-PUB: Modeling the Prediction of Improvement on Gait and Cognition among Patients Receiving Intranasal Insulin

Diabetes

Long H Ngo

Vera Novak

Peter Novak

Christos Mantzoros

Weiying Dai

...

2022/6/1

219-OR: intranasal insulin enhanced resting-state functional connectivity of medio-prefrontal cortex in type 2 diabetes: a substudy of the memory advancement with type 2 …

Diabetes

Zongpai Zhang

Vera Novak

Peter Novak

Christos Mantzoros

Long H Ngo

...

2022/6/1

879-P: Dropout Risk and Effectiveness of Retention Strategies: A Substudy of the Memory Advancement by Intranasal Insulin (INI) in Type 2 Diabetes (MemAID)

Diabetes

Faizan Khan

Daniel F Isaza-Pierotti

Peter Novak

Christos Mantzoros

Long H Ngo

...

2021/6/1

718-P: Long-Term Safety of Intranasal Insulin (INI) in Insulin-Dependent Type 2 Diabetes (T2DM-IDDM): A Safety Substudy of Memory Advancement by Intranasal Insulin in Type 2 …

Diabetes

Laura Aponte Becerra

Brahyan Galindo Mendez

Faizan Khan

Christos Mantzoros

Peter Novak

...

2021/6/1

Glycemic variability of acute stroke patients and clinical outcomes: a continuous glucose monitoring study

Therapeutic Advances in Neurological Disorders

Lina Palaiodimou

Vasileios-Arsenios Lioutas

Vaia Lambadiari

Aikaterini Theodorou

Marios Themistocleous

...

2021/9

719-P: Caloric Intake, Appetite, and Body Composition Outcomes of Long-Term Intranasal Insulin (INI) Administration: A Substudy of the Memory Advancement by INI in Type 2 …

Diabetes

Laura Aponte Becerra

Faizan Khan

Long H Ngo

Vera Novak

CHRISTOS MANTZOROS

...

2021/6/1

Placebo controlled phase II clinical trial: Safety and efficacy of combining intranasal insulin & acute exercise

Metabolic brain disease

Kathryn L Gwizdala

David P Ferguson

Jeffery Kovan

Vera Novak

Matthew B Pontifex

2021/8

Tai Chi training’s effect on lower extremity muscle co-contraction during single-and dual-task gait: Cross-sectional and randomized trial studies

PLoS One

Peter M Wayne

Brian J Gow

Fengzhen Hou

Yan Ma

Jeffrey M Hausdorff

...

2021/1/22

Deep transfer learning and data augmentation improve glucose levels prediction in type 2 diabetes patients

NPJ Digital Medicine

Yixiang Deng

Lu Lu

Laura Aponte

Angeliki M Angelidi

Vera Novak

...

2021/7/14

193-OR: Memory Advancement with Intranasal Insulin in Type 2 Diabetes: Randomized Control Trial

Diabetes

Vera Novak

Christos Mantzoros

Peter Novak

Regina McGlinchey

Weiying Dai

...

2021/6/1

Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale

Contemporary clinical trials

B Galindo-Mendez

JA Trevino

R McGlinchey

C Fortier

V Lioutas

...

2020/2/1

Non-invasive strategies for nose-to-brain drug delivery

Journal of clinical trials

JT Trevino

RC Quispe

F Khan

V Novak

2020

Dysregulation of behavioral and autonomic responses to emotional and social stimuli following bidirectional pharmacological manipulation of the basolateral amygdala in macaques

Neuropharmacology

Catherine Elorette

Brittany L Aguilar

Vera Novak

Patrick A Forcelli

Ludise Malkova

2020/11/15

See List of Professors in Vera Novak University(Harvard University)